Detalles de la búsqueda
1.
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial.
Ann Rheum Dis
; 82(11): 1394-1403, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607809
2.
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.
JAMA
; 325(17): 1755-1764, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33944875
3.
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial.
Lancet Rheumatol
; 6(5): e268-e278, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583450
4.
ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.
Ann Rheum Dis
; 74(8): 1627-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25917849
5.
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.
Nat Commun
; 6: 7146, 2015 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25994336
Resultados
1 -
5
de 5
1
Próxima >
>>